Rogers J S, Shane S R
J Lab Clin Med. 1983 Sep;102(3):444-9.
We have previously reported that plasma factor VIII levels are elevated in hyperthyroidism and present here the effects of oral thyroid hormone and oral beta-adrenergic blockade on factor VIII in normal male volunteers. Oral levothyroxine in 14 volunteers and oral liothyronine in nine volunteers produced significant percentage increases in resting pulse and factor VIII-related activities (factor VIII coagulant activity, factor VIII-related antigen, and ristocetin co-factor activity). The addition of oral beta-adrenergic blockade significantly reduced or prevented elevations in resting pulse but not increases in factor VIII-related properties. These findings are discussed with reference to possible regulatory mechanisms for plasma factor VIII levels related to alterations in thyroid function.
我们之前曾报道甲状腺功能亢进时血浆凝血因子VIII水平升高,在此呈现口服甲状腺激素和口服β-肾上腺素能阻滞剂对正常男性志愿者凝血因子VIII的影响。14名志愿者口服左甲状腺素,9名志愿者口服三碘甲状腺原氨酸,静息脉搏和凝血因子VIII相关活性(凝血因子VIII促凝活性、凝血因子VIII相关抗原和瑞斯托霉素辅因子活性)出现显著百分比升高。口服β-肾上腺素能阻滞剂可显著降低或阻止静息脉搏升高,但不能阻止凝血因子VIII相关特性升高。结合甲状腺功能改变相关的血浆凝血因子VIII水平可能的调节机制对这些发现进行了讨论。